ArticleWideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques2026
Thulium laser enucleation of the prostate vs bipolar transurethral resection of the prostate in moderate-to-large prostates: perioperative and functional outcomes.
Article in Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThulium laser enucleation of the prostate (ThuLEP) and bipolar transurethral resection of the prostate (bipolar TURP) are established surgical therapy alternatives that have proved effective in treating benign prostatic hyperplasia (BPH).
aimThis study aimed to compare perioperative and functional results obtained in patients with moderate-to-large BPH treated with ThuLEP and bipolar TURP. MATERIALS AND
methodsThis was a retrospective multicenter study of 154 men at a mean (SD) age of 68.4 (7.9) years, who received ThuLEP (n = 78) or bipolar TURP (n = 76) in 2018-2024 in 2 hospitals in Amman, Jordan. The collected data included demographics, comorbidities, perioperative variables, complications, and functional outcomes at 1 and 6 months postoperatively.
resultsThuLEP was associated with greater mean (SD) tissue removal (61.4 [18.2] vs 44.9 [14.6] g;
conclusionsThuLEP is safer and more effective in patients with moderate-to-large volume prostates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.